Thus, considering the effect of sodium excreting and activating PPARG, patients with DN may benefit more from combination of dapagliflozin and thiazolidinedione than a single therapy, which was supported by previous studies (50). This evidence concerns the gene PPARG and liver dysplastic nodule.